Affimed Therapeutics Closes €20M Series C Financing Round
Affimed Therapeutics AG, a Heidelberg, Germany-based therapeutic antibody company developing antibody therapeutics as novel treatments for life threatening diseases, closed a €20m Series C financing round. The round was lead by existing investors aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk A/S and Orbimed. The capital will be used to fund the clinical validation […]